Multi-Action Dry Eye Drops

Systane PRO PF Hydrates, Restores and Protects Dry Eyes

Alcon is expanding dry eye care in Canada with Systane PRO Preservative-Free, a triple-action eye drop designed to hydrate, restore tear-film stability, and protect against further dryness. The formula combines HP-guar, hyaluronic acid, nano-sized lipids, and propylene glycol to address multiple components of dry eye within one product. According to Alcon, the drops provide up to 12 hours of symptom relief, making them the longest-lasting option in the current Systane portfolio. The preservative-free format is intended for all types of dry eye.

The launch strengthens Alcon’s ability to serve consumers experiencing dry eye from factors such as aging, environmental conditions, and digital device use. By adding a more comprehensive formula alongside Systane Complete, Ultra, Balance, and Hydration, Alcon can address different symptom profiles and consumer preferences within one established brand. The Canadian introduction also expands the company’s premium eye-care portfolio with a longer-lasting treatment option.

Image Credit: Alcon

Multi-action Eye Care
Combination formulas that hydrate, restore, and protect reflect a shift toward simplified treatments for consumers managing complex dry eye symptoms.
Preservative-free Wellness
Preservative-free formats are creating premium opportunities in everyday health products by appealing to sensitivity-conscious and frequent-use consumers.
Digital Strain Relief
Rising screen exposure is increasing demand for longer-lasting eye comfort solutions tailored to modern lifestyle-related dryness.

Sectors Adopting This

Vision Care
Advanced tear-film technologies are reshaping over-the-counter eye care with products that address multiple causes of irritation in one format.
Consumer Health
Premium self-care treatments are expanding as shoppers seek clinically positioned products that deliver convenience, comfort, and extended relief.
Pharmaceuticals
Specialized delivery systems and multi-ingredient formulations are opening new competitive space within non-prescription therapeutic categories.
SCORE
3.9 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Z
  • Gen Alpha
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 8%
Activity 8%
Freshness 100%